| Document Date: 2013-10-04 12:59:17
Open Document File Size: 308,56 KBShare Result on Facebook
City Mississauga / Victoria / / Company IgG / GlaxoSmithKline Inc. / ID Biomedical Corporation / Dosage Adjustment Age Group / / Continent Europe / / Country United States / Canada / / Event FDA Phase / / Facility Laboratory Tests False / / IndustryTerm injection site / hydrochloride solution / / MedicalCondition people receiving influenza / anaphylactic reaction / mild infection / demyelinating disease / labyrinthitis / severe oculo-respiratory syndrome / HIV / headache / active infection / flu / hives / prior influenza / Neurologic If Guillain-Barré syndrome / facial paralysis / infectious / Hepatitis C / hepatitis B / active neurologic disorder / Syncope / fatigue / injury / encephalopathy / systemic anaphylaxis / acute anaphylactic reaction / acute respiratory infection / angioedema / allergic asthma / influenza virus / Infections / influenza / hemophilia / hypotension / sore throat / influenza disease / serious febrile illness / disease / arthralgia / hoarseness / aches / Reye's syndrome / chills / shock / split-virion influenza / fever / allergy / pain / urticaria / encephalitis / Angioedema / Allergic reactions / suspected hypersensitivity / chest tightness / infection / cough / syndrome / disorders / / MedicalTreatment Immunization / active immunization / Vaccination / immunosuppression / immunosuppressive therapy / / Organization World Health Organization / National Advisory Committee on Immunization / / Position Prime Minister / General / CAFV16/PM / / Product acetaminophen / Strength Clinically Relevant Nonmedicinal Ingredients Suspension / theophylline / epinephrine / prednisone / Influenza vaccine / FLUVIRAL® / / ProvinceOrState Texas / Victoria / California / Massachusetts / Ontario / / Technology antibodies / Pharmacokinetics / Pharmacodynamics / /
SocialTag |
PRODUCT MONOGRAPH FLUVIRAL® ([removed]Influenza Virus Vaccine Trivalent, Inactivated Split Virion